It was recently reported that in patients with autoimmune diseases such as rheumatoid arthritis, treatment with tumor necrosis factor (TNF) inhibitor increased the risk of CNS inflammation and subsequent BBB breakdown.5 This evidence concerns the gene TNF and rheumatoid arthritis.